BlueBox Precision Medicine R UK GBP Acc
Pricing frequency
Daily
Dealing cut off time
14:45
Type
SICAV
Yield
–
NAV
£1,468.00
Income frequency
-
Ongoing charge
1.54%
Latest actual NAV date
16-11-2026
ISIN
LU2992394382
UCITS
Yes
Growth of 10k
Asset allocation
Top 10 holdings
| Holdings 31/10/2026 | % of assets |
|---|---|
| BridgeBio Pharma Inc | 6.65 |
| argenx SE | 5.56 |
| Vertex Pharmaceuticals Inc | 5.35 |
| Revolution Medicines Inc Ordinary Shares | 4.66 |
| Rhythm Pharmaceuticals Inc | 4.49 |
| Guardant Health Inc | 4.36 |
| Danaher Corp | 4.10 |
| BioMarin Pharmaceutical Inc | 4.08 |
| Sartorius Stedim Biotech SA | 4.05 |
| Ionis Pharmaceuticals Inc | 4.01 |
Investment objective
The Fund is actively managed and its main objective is to seek to maximise total return. The BlueBox Precision Medicine Fund invests globally with at least 85% of its total assets in the equity securities of companies whose predominant economic activity is in the pharmaceuticals, biotechnology and life science sectors. The remaining 15% of the total assets of the BlueBox Precision Medicine Fund may be invested in equity securities of companies or issuers of any size in any sector of the economy globally and whose predominant economic activity is not in the pharmaceuticals, biotechnology and life science sectors.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.